Sensei Biotherapeutics Inc (SNSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,085 | -30,157 | -34,101 | -48,588 | -36,794 |
| Depreciation Amortization | 139 | 1,322 | 1,351 | 1,347 | 685 |
| Other Working Capital | -1,592 | -489 | -4,330 | 1,008 | 117 |
| Other Operating Activity | 2,085 | 4,654 | 5,057 | 7,207 | 5,733 |
| Operating Cash Flow | $-20,453 | $-24,670 | $-32,023 | $-39,026 | $-30,259 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 19,538 | 22,586 | 38,426 | 50,255 | -141,410 |
| PPE Investments | 234 | -146 | -14 | -306 | -1,708 |
| Investing Cash Flow | $19,772 | $22,440 | $38,412 | $49,949 | $-143,118 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 142 | N/A | N/A | N/A | N/A |
| Debt Repayment | -790 | -811 | -761 | -629 | 0 |
| Common Stock Issued | 2 | N/A | N/A | 238 | 140,623 |
| Common Stock Repurchased | N/A | N/A | -10,384 | N/A | N/A |
| Other Financing Activity | 1 | 24 | -28 | 104 | 23,317 |
| Financing Cash Flow | $-645 | $-787 | $-11,173 | $-287 | $163,940 |
| Beginning Cash Position | 9,994 | 13,011 | 17,795 | 7,159 | 16,596 |
| End Cash Position | 8,668 | 9,994 | 13,011 | 17,795 | 7,159 |
| Net Cash Flow | $-1,326 | $-3,017 | $-4,784 | $10,636 | $-9,437 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,453 | -24,670 | -32,023 | -39,026 | -30,259 |
| Capital Expenditure | -16 | -146 | -180 | -321 | -2,026 |
| Free Cash Flow | -20,469 | -24,816 | -32,203 | -39,347 | -32,285 |